Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix B Public Meeting Agendas Committee on Public Health Interventions and Countermeasures for Advancing Pandemic and Seasonal Influenza Preparedness and Response First Committee Meeting March 2, 4, and 5, 2021, at 8:00 p.m.â11:00 p.m. ET Virtual Platforms Meeting Objectives â¢ Conduct committee and staff introductions â¢ Orient the committee to the National Academies consensus study process â¢ Conduct the bias and conflict of interest discussion â¢ Hold an open session to hear from sponsoring agency on their perspective of the Statement of Task â¢ Hear from external speakers to get a landscape of the issues related to each task â¢ Discuss the Statement of Task and agree on an approach for completing the study â¢ Identify information needs and workplan for addressing the Statement of Task 183 PREPUBLICATION COPYâUncorrected Proofs
184 NON-VACCINE INFLUENZA INTERVENTIONS Tuesday, March 2, 2021 CLOSED SESSIONâCOMMITTEE MEMBERS ONLY OPEN SESSION Sponsor Briefing: Discussion of the Committeeâs Charge 9:30 p.m. Welcome and Introductions Alexander Capron, Committee Chair Professor University of Southern California Patricia GarcÃa, Committee Vice Chair Professor Universidad Peruana Cayetano Heredia 9:35 p.m. Sponsor Perspective on Charge to the Committee Larry Kerr, Sponsor Director, Pandemics and Emerging Threats Office of Global Affairs U.S. Department of Health and Human Services 9:45 p.m. Discussion with Committee Speaker and Discussion on Therapeutics 10:05 p.m. Welcome and Introduction from the Moderator Marybeth Sexton Assistant Professor Emory University 10:06 p.m. Public Health Use of Therapeutics for Influenza Preparedness Matthew Wynia Director, Center for Bioethics University of Colorado Frederick Hayden Professor University of Virginia PREPUBLICATION COPYâUncorrected Proofs
APPENDIX B 185 10:20 p.m. Discussion with Committee (and public, if time allows) 11:00 p.m. ADJOURN OPEN SESSION AND DAY 1 OF MEETING Thursday, March 4, 2021 OPEN SESSION Speaker and Discussion on Effectiveness of Non-Vaccine Control Measures 8:00 p.m. Welcome and Introduction from the Moderator Raina MacIntyre Professor University of New South Wales, Australia 8:01 p.m. Effectiveness of Non-Vaccine Influenza Control Measures Don Milton Professor University of Maryland Ben Cowling Professor The Hong Kong University 8:20 p.m. Discussion with Committee (and public, if time allows) 8:50 p.m. Break Speaker and Discussion on Implementation of Non-Vaccine Control Measures 9:00 p.m. Welcome and Introduction from the Moderator Alex Capron Professor University of Southern California PREPUBLICATION COPYâUncorrected Proofs
186 NON-VACCINE INFLUENZA INTERVENTIONS 9:01 p.m. Implementation Factors of Non-Vaccine Influenza Control Measures Sheila Jasanoff Professor Harvard University Kumanan Rasanathan Former Coordinator, Health Systems, World Health Organization Cambodia (and Incident Manager, COVID-19, from March to June 2020) 9:20 p.m. Discussion with Committee 9:50 p.m. Break CLOSED SESSIONâCOMMITTEE MEMBERS ONLY 11:00 p.m. ADJOURN CLOSED SESSION AND DAY 2 OF MEETING Friday, March 5, 2021 OPEN SESSION Speaker and Discussion on Surveillance 8:00 p.m. Welcome and Introduction from the Moderator Tolbert Nyenswah Senior Research Associate Johns Hopkins University 8:01 p.m. Surveillance for Influenza Wenqing Zhang (via recorded video) Head, Global Influenza Programme World Health Organization John Simpson Deputy Director, Health Protection Directorate Public Health England 8:20 p.m. Discussion with Committee 8:50 p.m. Break PREPUBLICATION COPYâUncorrected Proofs
APPENDIX B 187 CLOSED SESSIONâCOMMITTEE MEMBERS ONLY 11:00 p.m. ADJOURN MEETING Second Committee Meeting Speaker Session Agenda on Therapeutics Research April 22, 2021, at 4:00 p.m.â5:00 p.m. EDT Location: Virtual Contact: firstname.lastname@example.org Meeting Objective â¢ Hear from key expertise regarding the evidence base for and process of researching novel or repurposed therapeutics for respiratory viruses during a pandemic, in particular how the experience from COVID-19 so far could strengthen future influenza preparedness. Thursday, April 22, 2021 4:00â5:00 p.m. EDTâOPEN SESSION Speakers and Discussion on Therapeutics Research 4:00 p.m. Welcome and Introduction from the Moderator Marybeth Sexton Assistant Professor Emory University 4:01 p.m. The Evidence Base and Research for Therapeutics During a Pandemic Christopher Seymour Associate Professor University of Pittsburgh 4:20 p.m. Discussion with Committee (and public, if time allows) 4:50 p.m. Break and Adjourn Open Session PREPUBLICATION COPYâUncorrected Proofs
188 NON-VACCINE INFLUENZA INTERVENTIONS Third Committee Meeting Speaker Session Agenda on Implementation Science April 23, 2021, at 7:00 a.m.â8:00 a.m. EDT Location: Virtual Contact: email@example.com Meeting Objective â¢ Hear from key speakers regarding the role of implementation science frame- works with implementing non-vaccine public health interventions during COVID-19. Friday, April 23, 2021 7:00â8:00 a.m. EDTâOPEN SESSION Speakers and Discussion on Implementation Science 7:00 a.m. Welcome and Introduction from the Moderator Patricia GarcÃa Professor Universidad Peruana Cayetano Heredia 7:01 a.m. Implementation Science and Frameworks Anjuli Wagner Assistant Professor University of Washington Arianna Means Assistant Professor University of Washington 7:20 a.m. Discussion with Committee (and public, if time allows) 7:50 a.m. Break and Adjourn Open Session PREPUBLICATION COPYâUncorrected Proofs